Lymphoma

Relapsed or Refractory Hodgkin Lymphoma: Optimizing Salvage Therapy

As novel therapies come on board for treating relapsed or refractory Hodgkin lymphoma, the field is advancing toward more personalized therapy. The goal...

Issues in Oncology

Changing Negative Perceptions on the Impact of Clinical Trials in Brazil

Clinical trials are an essential research tool to advance medical knowledge and patient care. Traditionally, the majority of pharmaceutical-sponsored clinical trials...

Lung Cancer

Hyperprogressive Disease in Advanced NSCLC Treated With PD-1/PD-L1 Inhibitors

In a French study reported in JAMA Oncology, Ferrara et al found that hyperprogressive disease appeared to be more common with programmed cell death protein 1...

 


Advertisement
Breast Cancer

Sequential vs Concurrent Neoadjuvant Therapy in HER2-Positive Breast Cancer

As reported in JAMA Oncology by Buzdar et al, the phase III ACOSOG Z1041 (Alliance) trial showed no difference in disease-free or overall survival with sequential vs concurrent...

 

Prostate Cancer

ASCO Endorses AUA/ASTRO/SUO Guideline on Clinically Localized Prostate Cancer

As reported in the Journal of Clinical Oncology by Justin E. Bekelman, MD, of the University of Pennsylvania Perelman School of Medicine, and colleagues, ASCO has endorsed...

 


More Top Stories

Lymphoma

Julie M. Vose, MD, MBA, on Lymphoma: Novel Pathways for Targeted Agents

Erratum

In the July 10, 2018, issue of The ASCO Post, the article “KEYNOTE-407: Pembrolizumab Plus Chemotherapy Benefits Response, Survival in Squamous NSCLC” contained an error in the regimen for pembrolizumab (Keytruda). The study regimen, which has been corrected in the online version on ASCOPost.com,...

Advertisement

Estimated Medicare Cost for Prostate Cancer Care in Older Men

Although national guidelines recommend against prostate cancer screening in men age 70 and older, researchers from the University of North Carolina (UNC) Lineberger Comprehensive Cancer Center estimate that screening for and treating prostate cancer in men in this age group costs Medicare more than ...

Kidney Cancer

Laurence Albiges, MD, PhD, and Toni K. Choueiri, MD, on Metastatic RCC: Perspectives on the Carmena Trial

Ana María López, MD, MPH, Becomes Chief of Cancer Services at Sidney Kimmel

ANA MARÍA LÓPEZ, MD, MPH, has joined the Sidney Kimmel Cancer Center (Sidney Kimmel), Jefferson Health, as Vice Chair of Medical Oncology and Chief of Cancer Services. Dr. López brings her expertise in breast and gynecologic cancers, integrative medicine, telehealth, and cancer disparities with...

Issues in Oncology
Global Cancer Care

NCCN and CAOH Develop Guidelines to Improve Cancer Care in the Caribbean

The National Comprehensive Cancer Network® (NCCN®) is embarking on a new collaboration with the Caribbean Association for Oncology & Hematology (CAOH) to develop a library of NCCN Harmonized Guidelines™ for the Caribbean. The archipelago that extends from the Bahamas in the north to Trinidad...

FDA Accepts sBLA for Pembrolizumab Monotherapy in First-Line Treatment of Locally Advanced or Metastatic PD-L1–Expressing NSCLC

The U.S. Food and Drug Administration (FDA) granted Priority Review to a new supplemental biologics license application (sBLA) seeking approval for pembrolizumab (Keytruda) as monotherapy for first-line treatment of locally advanced or metastatic nonsquamous or squamous non–small cell lung...

Issues in Oncology

Andrew D. Seidman, MD, on Embracing Computer-Assisted Decision-Making

Skin Cancer

No Improvement in Survival Reported With Epacadostat Plus Pembrolizumab in Advanced Melanoma

IN PATIENTS with unresectable or metastatic melanoma, adding epacadostat to pembrolizumab (Keytruda) did not result in greater clinical benefit over pembrolizumab alone, according to data from the phase III ECHO-301/KEYNOTE-252 study. These results were originally presented at the 2018 ASCO Annual...

Advertisement

ASCO Endorses AUA/ASTRO/SUO Guideline on Clinically Localized Prostate Cancer

As reported in the Journal of Clinical Oncology by Justin E. Bekelman, MD, of the University of Pennsylvania Perelman School of Medicine, and colleagues, ASCO has endorsed the 2017 American Urological Association (AUA), American Society for Radiation Oncology (ASTRO), and Society of Urologic...


By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.